Physicochemical Properties
| Molecular Formula | C9H12N2NA2O12P2 |
| Molecular Weight | 448.12 |
| Exact Mass | 628.029 |
| CAS # | 27821-45-0 |
| Related CAS # | Uridine 5'-diphosphate sodium salt;21931-53-3 |
| PubChem CID | 6031 |
| Appearance | White to off-white solid powder |
| LogP | -4.7 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 25 |
| Complexity | 676 |
| Defined Atom Stereocenter Count | 4 |
| SMILES | C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)O |
| InChi Key | XCCTYIAWTASOJW-XVFCMESISA-N |
| InChi Code | InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 |
| Chemical Name | [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | P2Y6 Receptor |
| ln Vitro | Microglia dramatically upregulates the expression of CCL2 and CCL3 mRNA when exposed to uridine-5'-diphosphate disodium salt (100 μM; 15 min). Microglia are induced to express chemokines by uridine-5'-diphosphate disodium salt (100 μM; 3 hours) [2]. In 30 minutes, mRNA encoding CCL2 and CCL3 is induced to express; this expression reaches a maximum level at 1 hour and returns to the base level after 3–12 hours when uridine-5'-diphosphate disodium salt (100 μM; 0.5, 1, 3, 6 12 hours) is added. Chemokine expression is increased concentration-dependently at the mRNA and protein levels when uridine-5'-diphosphate disodium salt (10, 100, and 1000 μM) is added during a three-hour period. Microglia exhibit activation of NFATc1 and NFATc2 with exposure to 100 μM uridine-5'-diphosphate disodium salt for 15 minutes [2]. Although it is not an antagonist of the rat P2Y14 receptor, uridine-5'-diphosphate disodium salt is a competitive antagonist of the human P2Y14 receptor (pEC50=7.28) [1]. Strong P2Y14 agonist UDP-glucose (UDPG; HY-N7032) [3][4]. |
| Cell Assay |
RT-PCR[2] Cell Types: Primary microglia Tested Concentrations: 100 μM Incubation Duration: For 15 min Experimental Results: Dramatically induced microglial CCL2 and CCL3 mRNA expression. |
| References |
[1]. Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal. 2009 Mar;5(1):75-89. [2]. Uridine 5'-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J Immunol. 2011 Mar 15;186(6):3701-9. [3]. Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation. Oncotarget. 2016 Oct 25;7(43):69358-69370. [4]. UDP-sugars activate P2Y 14 receptors to mediate vasoconstriction of the porcine coronary artery. Vascul Pharmacol. 2018 Apr;103-105:36-46. |
| Additional Infomation |
UDP is a uridine 5'-phosphate and a pyrimidine ribonucleoside 5'-diphosphate. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a conjugate acid of an UDP(3-). Uridine 5'-diphosphate is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Sdccgsbi-0051172.P002 has been reported in Helianthus tuberosus, Homo sapiens, and other organisms with data available. A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. |
Solubility Data
| Solubility (In Vitro) |
H2O : 100 mg/mL (223.15 mM) DMSO : 1 mg/mL (2.23 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (223.15 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2315 mL | 11.1577 mL | 22.3155 mL | |
| 5 mM | 0.4463 mL | 2.2315 mL | 4.4631 mL | |
| 10 mM | 0.2232 mL | 1.1158 mL | 2.2315 mL |